Search results
Results from the WOW.Com Content Network
Desmopressin, sold under the trade name DDAVP among others, is a medication used to treat diabetes insipidus, bedwetting, hemophilia A, von Willebrand disease, and high blood urea levels. [1] In hemophilia A and von Willebrand disease, it should only be used for mild to moderate cases. [ 1 ]
Vasopressin analogues are synthetic peptides structurally and functionally similar to arginine vasopressin (AVP), a naturally occurring hormone in mammals. These compounds have been developed to target specific vasopressin receptors ( V1 , V2 , and V3 ) with varying affinities, allowing for more tailored therapeutic applications.
Vasopressin agonists are used therapeutically in various conditions, and its long-acting synthetic analogue desmopressin is used in conditions featuring low vasopressin secretion, as well as for control of bleeding (in some forms of von Willebrand disease and in mild haemophilia A) and in extreme cases of bedwetting by children.
551 11998 Ensembl ENSG00000101200 ENSMUSG00000037727 UniProt P01185 P35455 RefSeq (mRNA) NM_000490 NM_009732 RefSeq (protein) NP_000481 NP_033862 Location (UCSC) Chr 20: 3.08 – 3.08 Mb Chr 2: 130.42 – 130.42 Mb PubMed search Wikidata View/Edit Human View/Edit Mouse Human vasopressin, also called antidiuretic hormone (ADH), arginine vasopressin (AVP) or argipressin, is a hormone synthesized ...
He is currently an emeritus professor of clinical psychiatry at the University of California, San Diego, and director of its Center for Criminality & Addiction Research, Training & Application. By the early ’70s, variations of the Game used on addicts and other crude behavior-modification techniques caught the attention of Congress.
College Football Playoff quarterfinals Fiesta Bowl. No. 6 Penn State vs. No. 3 Boise State. Date: Dec. 31 | Time: 7:30 p.m. ET | TV: ESPN | Line: Penn State -10.5 | Total: 52.5 The Nittany Lions ...
Shares of the San Jose, California-based company fell nearly 8% in extended trading. The company forecast annual revenue for 2025 between $23.30 billion and $23.55 billion, compared with estimates ...
Nephrogenic DI may be treated by addressing the underlying cause or by the use of a thiazide, aspirin or ibuprofen. [1] The number of new cases of diabetes insipidus each year is 3 in 100,000. [4] Central DI usually starts between the ages of 10 and 20 and occurs in males and females equally. [2] Nephrogenic DI can begin at any age. [3]